- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 515/18 - Bridged systems
Patent holdings for IPC class C07D 515/18
Total number of patents in this class: 86
10-year publication summary
|
1
|
1
|
1
|
4
|
5
|
11
|
9
|
6
|
6
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1582 |
7 |
| Genzyme Corporation | 1368 |
7 |
| Sionna Therapeutics, Inc. | 26 |
6 |
| Janssen Pharmaceutica N.V. | 3168 |
3 |
| Elanco Animal Health Ireland Limited | 3 |
3 |
| Oncodesign S.A. | 16 |
3 |
| Inflazome Limited | 84 |
3 |
| Captor Therapeutics S.A. | 37 |
3 |
| Sobi, Inc | 29 |
3 |
| Novartis AG | 10262 |
2 |
| Atrin Pharmaceuticals LLC | 8 |
2 |
| Esperion Therapeutics, Inc. | 68 |
2 |
| Istituto Nazionale di Genetica Molecolare-ingm | 24 |
2 |
| Janssen Sciences Ireland UC | 158 |
2 |
| Les Laboratoires Servier | 496 |
2 |
| Ospedale San Raffaele S.r.l. | 312 |
2 |
| Polyphor AG | 72 |
2 |
| S*BIO Pte Ltd. | 20 |
2 |
| Irbm S.p.A. | 27 |
2 |
| Sionna Therapeutics | 5 |
2 |
| Other owners | 26 |